key: cord-1031964-fhyu6gje authors: Lee, R. A.; Herigon, J. C.; Benedetti, A.; Pollock, N. R.; Denkinger, C. title: Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: A Systematic Review and Meta-analysis date: 2020-11-13 journal: nan DOI: 10.1101/2020.11.12.20230748 sha: b64ac359e915a3a9ff51c4b840469bd9b4b17d45 doc_id: 1031964 cord_uid: fhyu6gje Background: Nasopharyngeal (NP) swabs are considered the highest-yield sample for diagnostic testing for respiratory viruses, including SARS-CoV-2. The need to increase capacity for SARS-CoV-2 testing in a variety of settings, combined with shortages of sample collection supplies, have motivated a search for alternative sample types with high sensitivity. We systematically reviewed the literature to understand the performance of alternative sample types compared to NP swabs. Methods: We systematically searched PubMed, Google Scholar, medRxiv, and bioRxiv (last retrieval October 1st, 2020) for comparative studies of alternative specimen types [saliva, oropharyngeal (OP), and nasal (NS) swabs] versus NP swabs for SARS-CoV-2 diagnosis using nucleic acid amplification testing (NAAT). A logistic-normal random-effects meta-analysis was performed to calculate % positive alternative-specimen, % positive NP, and % dual positives overall and in sub-groups. The QUADAS 2 tool was used to assess bias. Results: From 1,253 unique citations, we identified 25 saliva, 11 NS, 6 OP, and 4 OP/NS studies meeting inclusion criteria. Three specimen types captured lower % positives [NS (0.82, 95% CI: 0.73-0.90), OP (0.84, 95% CI: 0.57-1.0), saliva (0.88, 95% CI: 0.81 -0.93)] than NP swabs, while combined OP/NS matched NP performance (0.97, 95% CI: 0.90-1.0). Absence of RNA extraction (saliva) and utilization of a more sensitive NAAT (NS) substantially decreased alternative-specimen yield. Conclusions: NP swabs remain the gold standard for diagnosis of SARS-CoV-2, although alternative specimens are promising. Much remains unknown about the impact of variations in specimen collection, processing protocols, and population (pediatric vs. adult, late vs. early in disease course) and head-to head studies of sampling strategies are urgently needed. . S a l i v a r y g l a n d d u c t 2 5 e p i t h e l i a l c e l l s p r e v i o u s l y w e r e i d e n t i f i e d a s a t a r g e t f o r S A R S -C o V i n a r h e s u s m a c a q u e m o d e l ( 8 ) . O n e 2 6 s t u d y d e t e c t e d S A R S -C o V -2 i n s a l i v a c o l l e c t e d v i a e x p r e s s i o n d i r e c t l y f r o m t h e s a l i v a r y g l a n d d u c t ( 9 ) . 2 7 T h e s e f i n d i n g s s u g g e s t t h a t s a l i v a m a y b e a s u i t a b l e a n d h i g h -y i e l d d i a g n o s t i c s a m p l e f o r S A R S -C o V -2 2 8 t e s t i n g b a s e d o n l o c a l v i r a l r e p l i c a t i o n , i n a d d i t i o n t o t h e p o s s i b l e m i x i n g i n s a l i v a o f l o w e r a n d u p p e r 2 9 r e s p i r a t o r y t r a c t f l u i d s t h a t c a n c a r r y v i r u s . S a l i v a o f f e r s s e v e r a l a d v a n t a g e s a s i t i s a n o n -i n v a s i v e s a m p l e 3 0 t y p e t h a t c a n b e s e l f -c o l l e c t e d , t h u s d e c r e a s i n g i n f e c t i o u s r i s k t o m e d i c a l p e r s o n n e l , u s e o f p e r s o n a l 3 1 p r o t e c t i v e e q u i p m e n t , a n d r e l i a n c e o n e q u i p m e n t s u b j e c t t o s u p p l y s h o r t a g e s s u c h a s n a s a l , O P , o r N P 3 2 s w a b s . 3 3 O P ( t h r o a t ) s w a b s h a v e b e e n i n w i d e u s e f o r S A R S -C o V -2 d i a g n o s i s s i n c e t h e b e g i n n i n g o f t h e p a n d e m i c 3 4 ( 3 ) . C o n s e n s u s i s l a c k i n g o n b o t h t h e b e s t c o l l e c t i o n a p p r o a c h a n d n o m e n c l a t u r e f o r o r a l s p e c i m e n s . T h e 3 5 t e r m s " o r o p h a r y n g e a l " a n d " t h r o a t " h a v e b e e n u s e d i n t h e l i t e r a t u r e , a n d t h e r e f o r e w e d e s c r i b e a n d 3 6 g r o u p t h e m h e r e a s " o r o p h a r y n g e a l " o r O P s w a b s . N o c o m p r e h e n s i v e e v a l u a t i o n s o f t h e i r p e r f o r m a n c e 3 7 c o m p a r e d t o o t h e r m e t h o d s e x i s t . O P s w a b s a r e l e s s s p e c i a l i z e d t h a n N P s w a b s a n d t h u s O P s a m p l e s 3 8 c a n b e c o l l e c t e d w i t h a b r o a d e r r a n g e o f s w a b p r o d u c t s . W h i l e t h e F D A r e c o m m e n d s t h a t O P s w a b s b e 3 9 c o l l e c t e d b y a h e a l t h c a r e p r o f e s s i o n a l ( 1 ) , s o m e h a v e s u g g e s t e d t h a t s e l f -s w a b b i n g m i g h t b e p o s s i b l e . 4 0 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint N a s a l s w a b s ( N S ) , a n o t h e r i m p o r t a n t a l t e r n a t i v e s p e c i m e n t y p e , a l s o h a v e t h e a d v a n t a g e s o f i n c r e a s e d 1 c o m f o r t a n d p o s s i b l e s e l f -c o l l e c t i o n . T h e y h a v e b e e n c l a s s i f i e d i n t o t w o t y p e s a n a t o m i c a l l y . N a s a l m i d -2 t u r b i n a t e ( M T ) s w a b s , a l s o c a l l e d d e e p n a s a l s w a b s , a r e d e f i n e d b y t h e C D C ( 2 ) a s f l o c k e d / t a p e r e d s w a b s 3 p e r f o r m e d w h i l e t i l t i n g t h e p a t i e n t ' s h e a d b a c k 7 0 d e g r e e s a n d i n s e r t i n g t h e s w a b l e s s t h a n o n e i n c h 4 ( a b o u t 2 c m i n t o t h e n o s t r i l ) u n t i l r e s i s t a n c e i s m e t a t t h e t u r b i n a t e s b e f o r e r o t a t i n g t h e s w a b s e v e r a l 5 t i m e s a g a i n s t t h e n a s a l w a l l . A n t e r i o r n a r e s ( A N ) s w a b s a r e d e f i n e d w i t h o u t a h e a d t i l t a n d i n s e r t i n g t h e 6 e n t i r e s w a b a t l e a s t 0 . 5 i n c h ( 1 c m ) i n s i d e t h e n o s t r i l ( n a r i s ) a n d s a m p l i n g t h e m e m b r a n e b y v a r i o u s 7 m e t h o d s , i n c l u d i n g r o t a t i n g t h e s w a b i n p l a c e o r a r o u n d t h e i n s i d e w a l l o f t h e n o s t r i l m u l t i p l e t i m e s , 8 a n d / o r l e a v i n g i n p l a c e f o r 1 0 t o 1 5 s e c o n d s . T h e c u r r e n t " l o w e r n a s a l s w a b " p r o t o c o l s a n c t i o n e d b y t h e y s y s t e m a t i c a l l y r e v i e w i n g a n d m e t a -a n a l y z i n g t h e l i t e r a t u r e o n t h i s t o p i c 1 8 a s s y s t e m a t i c r e v i e w a n d m e t a -a n a l y s i s i s r e p o r t e d i n a c c o r d a n c e w i t h P R I S M A g u i d e l i n e s ( s e e 2 1 S u p p l e m e n t a r y F i l e f o r t h e P R I S M A c h e c k l i s t ) . T h e p r o t o c o l f o r t h i s w o r k w a s r e g i s t e r e d i n t h e 2 2 I n t e r n a t i o n a l P r o s p e c t i v e R e g i s t e r o f S y s t e m a t i CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint u r s e a r c h y i e l d e d 1 , 2 5 3 u n i q u e c i t a t i o n s , o f w h i c h 2 5 w e r e i n c l u d e d i n t h e a n a l y s e s f o r s a l i v a , 1 1 f o r 2 N S , 6 f o r O P , a n d 4 f o r O P / N S s w a b s . R e a s o n s f o r e x c l u s i o n s o f s t u d i e s a r e l a i d o u t i n S u p p l e m e n t a r y 3 F i g u r e 1 . 4 5 T CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint O t h e r d i f f e r e n c e s i n s a m p l i n g b e t w e e n s t u d i e s i n c l u d e d a v o i d a n c e o f e a t i n g , d r i n k i n g , o r b r u s h i n g t e e t h 1 b e f o r e s p e c i m e n s u b m i s s i o n ( t y p i c a l l y 3 0 m i n u t e s t o 2 h o u r s ) . P r o t o c o l s t h a t s p e c i f i e d a v o i d a n c e o f 2 e a t i n g , d r i n k i n g , o r b r u s h i n g t e e t h p r i o r t o s a l i v a c o l l e c t i o n ( 2 2 , 2 3 , 2 6 , 3 1 -3 4 , 4 0 ) h a d h i g h e r % p o s i t i v e 3 s a l i v a , a l t h o u g h t h e d i f f e r e n c e w a s n o t s u . W e a l s o a s s e s s e d i f p a t i e n t s y m p t o m a t o l o g y c o u l d e x p l a i n v a r i a b l e d i a g n o s t i c p e r f o r m a n c e b e t w e e n 1 s a l i v a a n d N P s a m p l i n g . W e f o u n d t h a t o n l y a f e w s t u d i e s p r o v i d e d a s y m p t o m a t i c ( 1 6 , 1 9 , 2 3 3 ) / s y m p t o m a t i c p a t i e n t d a t a ( 1 7 , 1 8 , 2 1 -2 3 , 2 5 , 2 7 , 2 8 , 3 4 , 3 5 , 3 7 , 3 9 , 4 0 ) t h a t c o u l d b e p a r s e d a n d 3 e x t r a c t e d f o r a n a l y s i s . W e f o u n d t h a t % p o s i t i v e s a l i v a w a s s i m i l a r b e t w e e n a s y m p t o m a t i c a n d 4 s A n o t h e r o u t l i e r s t u d y i n t h i s d a t a s e t w a s a c o h o r t o f s y m p t o m a t i c p a t i e n t s ( 5 5 ) i n a W u h a n h o s p i t a l 1 e a r l y o n i n t h e p a n d e m i c w i t h u n u s u a l l y p o o r p e r f o r m a n c e o f O P s w a b T h e r e w e r e n o t s u f f i c i e n t d a t a i n t h e O P s w a b m e t a -3 a n a l y s i s t o a s s e s s t h e i m p a c t o f s y m p t o m a t o l o g y o r d u r a t i o n o f s y m p t o m s o n p e r c e n t p o s i t i v e t o t a l p o s i t i v e s f o r M T ) . I n t h i s s t u d y , b o t h t h e A N a n d M T s w a b s w e r e c o l l e c t e d f r o m b o t h n a r e s , a n d 1 t h e A N s w a b w a s u n f l o c k e d , w h e r e a s t h e M T s w a b w a s f l o c k e d . 2 W e f o u n d t h a t a m o r e s e n s i t i v e a s s a y ( L O D < 1 0 0 0 c o p i e s / m L ) ( 6 4 , 6 5 , 6 8 ) r e s u l t e d i n w o r s e p e r f o r m a n c e 3 o f N S i n c o m p a r i s o n t o a s s a y s w i t h L O D ≥ 1 0 0 0 c o p i e s / m L ( 3 2 , 5 4 , 5 T h e r e w e r e 2 t w o s t u d i e s ( 6 3 , 6 7 ) w i t h e x t r a c t a b l e d a t a t o a s s e s s t h e i m p a c t o f s y m p t o m d u r a t i o n p r i o r t o t e s t i n g , a n d 3 a l o w e r y i e l d a f t e r 7 d a y s w a s f o u n d a l t h o u g h t h e d i f f e r e n c e w a s n o t s u b s t a n t i a . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint s u b s t a n t i a l l y l o w e r r a t e o f d e t e c t i o n . O n e s t u d y ( 4 4 ) h a d t o b e e x c l u d e d f r o m t h e m e t a -a n a l y s i s d u e t o 1 n o n -s y n c h r o n o u s c o l l e c t i o n o f N P a n d s a l i v a s a m p l e s . T h i s s t u d y i s o f i n t e r e s t n e v e r t h e l e s s , a s i t t e s t e d 2 d i f f e r e n t R T -P C R p l a t f o r m s o n t h e s a m e s e t o f s a l i v a s p e c i m e n s u s i n g 3 d i f f e r e n t e x t r a c t i o n -f r e e 3 c o m m e r c i a l R T -P C R a s s a y s a g a i n s t a s t a n d a r d R T -P C R a s s a y w i t h e x t r a c t i o n a n d r e p o r t e d t h a t 7 9 , 8 1 , 4 a n d 5 2 s p e c i m e n s w e r e d e t e c t e d , r e s p e c t i v e l y , o u t o f a t o t a l o f 8 4 p o s i t i v e s p e c i m e n s d e t e c t e d o n t h e 5 s t a n d a r d a s s a y , i n d i c a t i n g t h a t c h o i c e o f e x t r a c t i o n -f r e e a s s a y m a t t e e s i z e t h a t n a s a l s w a b p e r f o r m a n c e i s l i k e l y h i g h l y d e p e n d e n t o n c o l l e c t i o n p r o c e d u r e , w h i c h 2 6 h a s i n t u r n e v o l v e d o v e r t i m e a n d a s u b s t a n t i a l a m o u n t o f d a t a r e m a i n e d u n p u b l i s h e d ( p e r s o n a l 2 7 c o m m u n i c a t i o n N i r a P o l l o c k ) . S e l f -c o l l e c t i o n a n d s i n g l e -n a r e s a m p l i n g t r e n d e d t o w a r d s h i g h e r a l t h o u g h 2 8 n o t s u b s t a n t i a l l y d i f f e r e n t % p o s i t i v e d e t e c t i o n , a l t h o u g h t h e s e r e s u l t s w e r e l a r g e l y d r i v e n b y t h e t w o 2 O v e r a l l , m u c h r e m a i n s u n k n o w n a b o u t t h e i m p a c t o n d i a g n o s t i c s e n s i t i v i t y o f v a r i a t i o n s i n s p e c i m e n 1 c o l l e c t i o n a n d p r o c e s s i n g p r o t o c o l s , a n d p e r f o r m a n c e i n s p e c i f i c k e y s u b -p o p u l a t i o n s ( a s y m p t o m a t i c v s . 2 s y m p t o m a t i c , p e d i a t r i c v s . a d u l t , l a t e v s . e a r l y t e s t i n g f r o m s y m p t o m o n s e t ) . W h i l e w e a s s e s s a g g r e g a t e 3 d a t a f r o m d i f f e r e n t s t u d i e s t o g a i n i n s i g h t i n t o t h e s e v a r i a b l e s , a l i m i t a t i o n o f t h i s m e t a -a n a l y s i s i s t h a t 4 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint 0 1 S u p p l e m e n t a r y M e t h o d s : 2 E x a m p l e s e a r c h m e t h o d e m p l o y e d i n s y s t e m a t i c r e v i e w a n d m e t a -a n a l y s i s : 3 T ) . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint 1 S u p p l e m e n t a r y T a b l e 1 : R i s k o f b i a s i n s a l i v a s t u d i e s 1 R e f . S t u d y R i s k o f b i a s A p p l i c a b i l i t y c o n c e r n s P a t i e n t s e l e c t i o n I n d e x T e s t R e f e r e n c e S t a n d a r d F l o w a n d T i m i n g P a t i e n t s e l e c t i o n I n d e x T e s t R e f e r e n c e S t a n d a r d ( 2 2 ) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint S u p p l e m e n t a r y T a b l e 2 : R i s k o f b i a s i n O P s w a b s t u d i e s 1 R e f . S t u d y R i s k o f b i a s A p p l i c a b i l i t y c o n c e r n s P a t i e n t s e l e c t i o n I n d e x T e s t R e f e r e n c e S t a n d a r d F l o w a n d T i m i n g P a t i e n t s e l e c t i o n I n d e x T e s t R e f e r e n c e S t a n d a r is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint 1 S u p p l e m e n t a r y T a b l e 4 : S a l i v a c o l l e c t i o n p r o c e d u r e s s p e c i f i e d i n m e t h o d o l o g y f o r m e t a -a n a l y s i s s t u d i e s 2 n / 2 5 t o t a l s t u d i e s ( % ) C o u g h i n g b e f o r e c o l l e c t i o n ( 3 4 , 3 7 ( 1 6 -3 2 , 3 5 , 3 6 , 3 8 , 3 9 , p t o m a t i c p a t i e n t s ( 1 7 , 1 8 , 2 1 -2 3 , 2 5 , 2 7 , 2 8 , 3 4 , 3 5 , 3 7 , 3 9 , 4 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint 4 1 2 S u p p l e m e n t a r y T a b l e 5 : N a s a l s w a b c o l l e c t i o n p r o c e d u r e s s p e c i f i e d i n m e t h o d o l o g y f o r m e t a -a n a l y s i s 3 CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint 6 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale. Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched. Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated. Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis). Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators. Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made. 12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis. Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). 5 Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I 2 ) for each meta-analysis. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint Section/topic # Checklist item Reported on page # 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies). Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified. 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram. Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations. Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). Tables 1-3 Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. 6-11, Fig. 1-6 Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. 6-11, Fig.1-6 Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15) . Supp. Fig. 3 Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16] ). Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers). Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias). Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research. 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.12.20230748 doi: medRxiv preprint 0 R e f e r e n c e s : Center for Devices and Radiological Health. FAQs on Testing for SARS-CoV-2 Centers for Disease Control and Prevention. Information for Laboratories about Coronavirus Posterior Oropharyngeal Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) A pneumonia outbreak associated with a new coronavirus of probable bat origin Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Salivary Glands: Potential Reservoirs for COVID-19 Asymptomatic Infection High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques Detection of SARS-CoV-2 in Saliva and Characterization of Oral Symptoms in COVID-19 Patients Editorial Concern-Possible Reporting of the Same Patients With COVID-19 in Different Reports Gargle lavage as a viable alternative to swab for detection of SARS-CoV-2 Detection of SARS-associated Coronavirus in Throat Wash and Saliva in Early Diagnosis QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies Metaprop: a Stata command to perform meta-analysis of binomial data Mass screening of asymptomatic persons for SARS-CoV-2 using saliva Equivalent SARS-CoV-2 viral loads between nasopharyngeal swab and saliva in symptomatic patients Saliva as a potential clinical specimen for diagnosis of SARS-CoV-2 EasyCOV : LAMP based rapid detection of SARS-CoV-2 in saliva Accelerated Emergency Use Authorization (EUA) Summary SARS-CoV-2 Assay Evaluation of symptomatic patient saliva as a sample type for the Abbott ID NOW COVID-19 assay Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2 Saliva is less sensitive than nasopharyngeal swabs for Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2 Noninvasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence Validation of a Self-administrable, Saliva-based RT-qPCR Test Detecting SARS-CoV-2 Evaluation of specimen types and saliva stabilization solutions for SARS-CoV-2 testing Comparing nasopharyngeal swab and early morning saliva for the identification of SARS-CoV-2 Saliva as a Diagnostic Specimen for SARS-CoV-2 by a PCR-Based Assay: A Diagnostic Validity Study Self-Collected Anterior Nasal and Saliva Specimens versus Healthcare Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2 Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers Posterior oropharyngeal salivafor the detection of SARS-CoV-2 Prospective comparison of saliva and nasopharyngeal swab sampling for mass screening for COVID-19 Saliva offers a sensitive, specific and non-invasive alternative to upper respiratory swabs for SARS-CoV-2 diagnosis Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2 Consistent Detection of 2019 Novel Coronavirus in Saliva Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS-CoV-2 Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19 Viral Load Kinetics of SARS-CoV-2 Infection in Saliva in Korean Patients: a Prospective Multi-center Comparative Study Saliva is a reliable tool to detect SARS-CoV-2 Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients SalivaDirect: Simple and sensitive molecular diagnostic test for SARS-CoV-2 surveillance Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 Validation of Saliva and Self-Administered Nasal Swabs for COVID-19 Testing Early Release -Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19 SARS-CoV2 Testing: The Limit of Detection Matters Saliva is not a useful diagnostic specimen in children with Coronavirus Disease Sensitivity of Nasopharyngeal, Nasal and Throat Swab for the Detection of SARS-CoV-2 Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously Oropharyngeal Secretion as Alternative for SARS-CoV-2 Detection Sensitivity of nasopharyngeal, oropharyngeal and nasal washes specimens for SARS-CoV-2 detection in the setting of sampling device shortage Performance of Oropharyngeal Swab Testing Compared With Nasopharyngeal Swab Testing for Diagnosis of Coronavirus Disease 2019-United States Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic Comparison of Patient-collected and Lab Technician-collected Nasopharyngeal and Oropharyngeal Swabs for Detection of COVID-19 by RT-PCR Clinical Utility of Buccal Swabs for Severe Acute Respiratory Syndrome Coronavirus 2 Detection in Coronavirus Disease 2019-Infected Children Swabs Collected by Patients or Health Care Workers for SARS Self-Collected Oral Fluid and Nasal Swabs Demonstrate Comparable Sensitivity to Clinician Collected Nasopharyngeal Swabs for Covid-19 Detection Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients Nasal Swab Sampling for SARS-CoV-2: a Convenient Alternative in Times of Nasopharyngeal Swab Shortage Comparing Nasopharyngeal and Mid-Turbinate Nasal Swab Testing for the Identification of SARS-CoV-2 Nasal-Swab Testing Misses Patients with Low SARS-CoV-2 Viral Loads Nasal Swab as Preferred Clinical Specimen for COVID-19 Testing in Children Is Nasopharyngeal Swab Comparable With Nasopharyngeal Aspirate to Detect SARS-CoV-2 in Children? Combined throat/nasal swab sampling for SARS-CoV-2 is equivalent to nasopharyngeal sampling A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2 Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected anterior nasal swab versus professionalcollected nasopharyngeal swab